Australian (ASX) Stock Market Forum

AXE - Archer Materials

I'm rather simple and I figure that if something is more complicated than me it might be worth something so I got me some of these a few weeks ago.

[edit] then I read that the potato has about twice as many chromosomes as a human. did I just buy a potato? Hmm, chips.
 
Could take a while before we know that answer @tinhat
Out of any speculation that you have ever done, there's a chance that this one could be the biggest.
Because of this, there's no need to put the house on it.
Ye canna win the meat tray if yer dunna buy ya ticket...o_O
 
Solid trend starting to show up from Friday.
I would expect to hear some news on the testing of the (tasty? Tinhat) chips.


Screenshot_20200909-135337.png
 
Mmmm, lab on a chip, nano technology. Brilliant.

Appointment of biotechnology manager
Archer Materials Limited (“Archer”, the “Company”, “ASX: AXE”) is pleased to announce that the
Company has appointed Dr Rebecca Soffe to the position of Manager, Biotechnology (“Appointment”).
Dr Soffe’s appointment to this newly created role is part of Archer’s strategy to commercially develop materials technology in the Company’s key vertical of Human Health.
Commenting on the Appointment, Archer CEO Dr Mohammad Choucair said, “Dr Soffe is a talented nanotechnologist with an exceptional background in building biosensor devices. Her track record for high impact innovation related to ‘Lab on a Chip’ technology is world-class and strongly aligns to Archer’s requirements for developing our key vertical of Human Health.
“One of the main reasons the Company raised funds through the recent Share Purchase Plan
was to hire new staff to expedite the development of our deep tech and the prosecution of related patents. Dr Soffe’s appointment is consistent with this strategy, and we look forward to working with Dr Soffe and expanding our team and capabilities.”
 
Quite sure the market hasn't factored the latest announcement in yet... just another succesful step on the way.
I hold high hopes on this.


12 October 2020
Chip build fast-tracked with qubit modelling

Highlights
• Computational models developed for the first time accurately predict
Archer’s 12CQ qubit behaviour, necessary for successful chip operation.

• Quantum mechanical models validate Archer’s 12CQ technology global competitive advantage and open the way for streamlined development.

• Accurate simulations could strengthen and grow Archer’s quantum computing patent portfolio in the near and long-term.

• Archer is well-funded to continue its 12CQ chip technology development, with a key focus on demonstrating few and single-qubit control prototypes.

Held.
 
5 November 2020
Archer’s A1 Biochip™ development commences

Highlights

• Archer commences its A1 Biochip™ development with the aim of building a lab-on-chip biosensing device capable of simplifying disease detection.

• The A1 Biochip™ is being built by the Archer team in a world-class
semiconductor chip prototyping foundry.

• Archer is working with a German biotech company to explore the on-chip conversion of in-demand commercial diagnostics.

• Lab-on-chip devices form part of the global multibillion dollar biotech economy, catalysed by advances in point of care diagnostics and testing*.

• Archer owns all the IP associated to the biochip technology, and the
Company is prosecuting related international patent applications.

*https://media-publications.bcg.com/BCG-The-Dawn-of-the-Deep-Tech-Ecosystem-Mar-2019.pdf
 
19 November 2020
Progress towards qubit control
Highlights
• First stages of Archer’s qubit control measurements are completed, advancing 12CQ chip development towards a significant technology
milestone.
• Archer is building qubit control devices and utilises over $150 million of world-class facilities and custom-built infrastructure to validate its
technology.
• Archer is one of few key players† building hardware (e.g. qubit processors) in the emerging multibillion dollar global quantum computing economy

You don't reckon the boat's largely been missed?
No.
If all goes well, Intel, Nvidia, Qualcomm, AMD etc will be queing up... with a potential 100 bagger plus in our hands.
The boat is still in port.
 
It still hasn't cracked its may high. Just meandering.
First patent granted for 12CQ quantum computing chip

Highlights
• Japanese patent granted for Archer’s 12CQ quantum computing qubit processor
• Major commercial milestone achieved with the grant of a patent protecting the 12CQ chip technology in a Top 5 global economy.
• Archer is one of few key players† developing a qubit processor chip in the emerging multibillion-dollar quantum computing industry
 
I still consider the boat is in port.

Now Rock ... We all should have listened ... Damn, I listened but did I act?

No I didn't, lol.

I'm getting too old ... I looked at this today and couldn't pull the trigger at $0.58

Too late for me now, but I hope you made/still make a few bob out of it and well done :singing:(That's you singing)
 
The world's first room-temperature quantum computer is in the final stages of development and is set to be installed at the Pawsey Supercomputing Centre in Perth and activated later this year.

 
I added to my holding recently at around the $1 mark.
Not worried about seeing it down to around 92 cent not long after, a little annoying, but such is life.
Just al minor dip on the long term outlook IMO.
 
Archer begins sub-10 nanometre biochip fabrication
Highlights
• Archer commences biosensor nanofabrication process to sub-10 nanometre size,
the current best-in-class in the semiconductor industry†.

• The significant reduction of size in biosensor components allows for hundreds of millions of biosensing devices on a 1 cm2 biochip.

• Miniaturisation to the sub-10 nanometre regime is a key requirement for the operation and end-use of Archer’s biochip.

• Some of the most sophisticated lithography facilities and systems for prototyping semiconductor devices are being utilised by Archer staff in Sydney, Australia.
 
Sale of all mineral tenements

Highlights
Archer executes a legally binding agreement to sell all of the company's mineral tenements
• At completion of the sale, Archer will receive 50 million shares in the capital of the buyer
• Share Consideration to be distributed in-specie to Archer shareholders.
• Tenement sale and purchase is subject to certain conditions precedent, including the buyer listing on ASX and Archer shareholders' approval of the transaction and the Share Consideration distribution.
• The buyer expects to list on ASX before September 2021.
• The Company’s business is simplified with Archer to become a pure play deep technology company.

-
going to be a while till the fat lady gets all the ducks in a row.
 
Top